SARS‐CoV‐2 RNA positive pediatric organ donors: A case report

Abstract Background Preliminary evidence suggests that non‐lung organ donation from resolved, asymptomatic or mildly symptomatic SARS‐CoV‐2 infected adults may be safe. However, several biological aspects of SARS‐CoV‐2 infection differ in children and the risk for transmission and outcomes of recipients from pediatric donors with SARS‐CoV‐2 infection are not well described. Methods We report two unvaccinated asymptomatic pediatric non‐lung organ deceased donors who tested positive for SARS‐CoV‐2 RNA by RT‐PCR. Donor One unexpectedly had SARS‐CoV‐2 RNA detected in nasopharyngeal swab and plasma specimens at autopsy despite several negative tests (upper and lower respiratory tract) in the days prior to organ recovery. Donor Two had SARS‐CoV‐ 2 RNA detected in multiple nasopharyngeal swabs but not lower respiratory tract specimens (endotracheal aspirate and bronchoalveolar lavage) during routine surveillance prior to organ recovery and was managed with remdesivir and monoclonal antibodies prior to organ recovery. Results Two hearts, two livers and four kidneys were successfully transplanted into seven recipients. No donor to recipient transmission of SARS‐CoV‐2 was observed and graft function of all organs has remained excellent for up to 7 months of followup. Conclusions Due to the persistent gap between organ availability and the number of children waiting for transplants, deceased pediatric patients with non‐disseminated SARS‐CoV‐2 infection, isolated to upper and/or lower respiratory tract, should be considered as potential non‐lung organ donors.

[1]  D. Klassen,et al.  Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Through Solid Organ Transplantation and Outcomes of Coronavirus Disease 2019 Among Recent Transplant Recipients. , 2022, Open forum infectious diseases.

[2]  M. Fogel,et al.  Longitudinal Assessment of Cardiac Outcomes of Multisystem Inflammatory Syndrome in Children Associated With COVID‐19 Infections , 2022, Journal of the American Heart Association.

[3]  L. Sugeng,et al.  Longitudinal Assessment of Global and Regional Left Ventricular Strain in Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) , 2022, Pediatric Cardiology.

[4]  K. Lentine,et al.  Use of Organs from SARS-CoV-2 Infected Donors: Is It Safe? A Contemporary Review , 2021, Current Transplantation Reports.

[5]  R. Lodha,et al.  Outcomes of multisystem inflammatory syndrome in children temporally related to COVID-19: a longitudinal study , 2021, Rheumatology International.

[6]  Cameron R. Wolfe,et al.  The pandemic provides a pathway: What we know and what we need to know about using COVID positive donors , 2021, Transplant infectious disease : an official journal of the Transplantation Society.

[7]  G. Tisone,et al.  Liver transplantation from active COVID-19 donors: A lifesaving opportunity worth grasping? , 2021, American Journal of Transplantation.

[8]  N. Desai,et al.  Evaluation of Racial and Ethnic Disparities in Cardiac Transplantation , 2021, Journal of the American Heart Association.

[9]  Kanwal M. Farooqi,et al.  Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children , 2021, Pediatrics.

[10]  E. Poggio,et al.  Early success transplanting kidneys from donors with new SARS-CoV-2 RNA positivity: A report of 10 cases , 2021, American Journal of Transplantation.

[11]  E. Bouza,et al.  Heart and liver transplant recipients from donor with positive SARS‐CoV‐2 RT‐PCR at time of transplantation , 2021, Transplant infectious disease : an official journal of the Transplantation Society.

[12]  Manish M Patel,et al.  Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2 , 2021, JAMA network open.

[13]  A. Friedman,et al.  Successful transplantation of organs from a deceased donor with early SARS-CoV-2 infection , 2021, American Journal of Transplantation.

[14]  S. Letovsky,et al.  A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States , 2021, EClinicalMedicine.

[15]  Deepali Kumar,et al.  A call to routinely test lower respiratory tract samples for SARS-CoV-2 in lung donors , 2021, American Journal of Transplantation.

[16]  C. Kedarisetty,et al.  Living Donor Hepatectomy After Proven SARS-CoV-2 Infection: First Report of 9 Cases From 3 Centers. , 2021, Transplantation.

[17]  M. Weiss,et al.  Evidence of SARS-CoV-2 Infection in Cells, Tissues, and Organs and the Risk of Transmission Through Transplantation , 2021, Transplantation.

[18]  A. Lauring,et al.  Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing , 2021, American Journal of Transplantation.

[19]  C. Brasher,et al.  Mandatory preoperative SARS-CoV-2 infection screening policies for paediatric surgery , 2021, British Journal of Anaesthesia.

[20]  V. Siddini,et al.  Is it Safe to Be Transplanted From Living Donors Who Recovered From COVID-19? Experience of 31 Kidney Transplants in a Multicenter Cohort Study From India , 2020, Transplantation.

[21]  S. Lindstrom,et al.  SARS-CoV-2 Infections among Recent Organ Recipients, March–May 2020, United States , 2020, Emerging Infectious Diseases.

[22]  G. Verleden,et al.  Successful double-lung transplantation from a donor previously infected with SARS-CoV-2 , 2020, The Lancet Respiratory Medicine.

[23]  Elaina E. Lin,et al.  Symptomatology and racial disparities among children undergoing universal preoperative COVID‐19 screening at three US children’s hospitals: Early pandemic through resurgence , 2020, Paediatric anaesthesia.

[24]  L. Plantinga,et al.  Variation in Racial Disparities in Liver Transplant Outcomes Across Transplant Centers in the United States , 2020, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[25]  V. Jiménez Yuste,et al.  No transmission of SARS-CoV-2 in a patient undergoing allogeneic hematopoietic cell transplantation from a matched-related donor with unknown COVID-19 , 2020, Transfusion and Apheresis Science.

[26]  J. Newburger,et al.  Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children. , 2020, Circulation.

[27]  M. Germain,et al.  Risk of transmission of severe acute respiratory syndrome coronavirus 2 by transfusion: A literature review , 2020, Transfusion.

[28]  S. Pakakasama,et al.  Hematopoietic stem cell transplantation from an infected SARS-CoV2 donor sibling , 2020, Bone Marrow Transplantation.

[29]  A. Limaye,et al.  Emerging evidence to support not always “just saying no” to SARS-CoV-2 positive donors , 2020, American Journal of Transplantation.

[30]  A. Limaye,et al.  Use of SARS-CoV-2-infected deceased organ donors: Should we always “just say no?” , 2020, American Journal of Transplantation.

[31]  H. Hong,et al.  A case of coronavirus disease 2019–infected liver transplant donor , 2020, American Journal of Transplantation.

[32]  G. Colditz,et al.  Racial/ethnic disparities in access and outcomes of simultaneous liver-kidney transplant among liver transplant candidates with renal dysfunction in the United States. , 2019, Transplantation.

[33]  H. Hedlin,et al.  Racial and ethnic disparities in lung transplant listing and waitlist outcomes. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[34]  Connie M. Rhee,et al.  Racial–ethnic disparities in mortality and kidney transplant outcomes among pediatric dialysis patients , 2017, Pediatric Nephrology.

[35]  F. Schaefer,et al.  Racial Disparities in Access to and Outcomes of Kidney Transplantation in Children, Adolescents, and Young Adults: Results From the ESPN/ERA-EDTA (European Society of Pediatric Nephrology/European Renal Association-European Dialysis and Transplant Association) Registry. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  M. A. O. Ignacio,et al.  How to cite this article , 2016 .